Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
Vaccines need to be tested more than ever. OO will be in BIG DEMAND!
Coronavirus
Covid-19 Has 7 Key Strains. Here's What You Need To Know
HuffPost UK
The Guardian
Coronavirus: Three billion could miss out on vaccine
The Independent
Coronavirus: ‘Unlikely’ that vaccine will be able to completely stop spread of virus, says chief government scientist
Samuel Lovett
The Independent19 October 2020, 7:13 pm
It is "unlikely" that a coronavirus vaccine will be able to completely stop the spread of infection, the government's chief science advicer.
Coronavirus - 19 will be endemic into the future according government scientist! So always need OO to test out vaccines. Notice the word vaccines and not just vaccine!
https://www.theguardian.com/world/2020/oct/19/covid-vaccine-will-not-be-available-in-uk-until-spring-says-vallance
No but the UK government seems to have loads of dosh as they are throwing it around at Covid 19 like nobody's business.
No but the UK government seems to have loads of dosh as they are throwing it around at Covid 19 like nobody's business.
Why sell IMUTEX? Is there any reason to sell it? Would it be better to develop IMUTEX to increase shareholders value??
WhatS RMS and why does it affect the share price so. Much???
What's happening with this Rns and share price today? Don't understand what is going on.
Can you buy this share on the London stock exchange? No one seems to be using this BB? WHY?
I think Open orphan will have many other opportunities for trying out drugs using Human challenge studies. Its not just for Covid-19 because there will be need for such other vaccines and treatments long into the future. Open orphan isn't just a one trip pony.. It also has other avenues to explore. So it's likely this companies share price will increase. Especially, if other governments and companies use open orphans facilities.
Re: Fathertedcrilly
Do you not see this share price going to £1.50 or more if there are more Covid-19 challenge studies being carried out by other countries / companies? As challenge studies are meant to spead up vaccines /testing. Which we are in great need of. Only asking as this challenge study seems important.
What exactly are these masks and does this company make that is important to Covid-19? New to this board!
It has been stated the world will need more than one vaccine. So there is a strong possibility that OO will be used by more than one vaccine manufacturer to test and evaluate it bf use on the whole world.
. What is the potential impact of accelerating the development of one additional vaccine?
We do not have the manufacturing or supply chain capacity to produce the billions of vaccine doses needed across the globe with just one vaccine. Accelerating the development of just one additional safe and effective vaccine by even a couple of days could save thousands of lives.
Measuring the exact impact is difficult. It is currently uncertain how many people COVID-19 will affect worldwide and at what speed its impacts will be felt. Possible outcomes are shaped by interventions like social distancing, the capacity of health systems, potential drug treatments, and many other factors. A vaccine may come after the infection has peaked or once effective pharmaceutical treatments have blunted COVID-19’s impact. But it is clear that COVID-19 will continue to alter daily life until an effective vaccine is fully deployed.
While any estimate is deeply uncertain, to give a sense of the scale of a vaccine’s impact, suppose that daily confirmed COVID-19 deaths remain at July 2020 average of around 5,000 per day. If an additional vaccine could avert just 25% of these deaths, then speeding up vaccine development by:
1 day saves 1,250 lives
1 week saves 8,750 lives
1 month saves 37,500 lives
3 months saves 112,500 lives
Who are BC and what do they do?
And are Genedrive trying to become accredited in the USA?
Vaccine makers will be competing with each other for space at OO especially for publicity of their own vaccines!
Did BB sell their share in Genedrive? Are they are stock broker who sold them?
Perhaps Hyvo is at the Webinar because of the anti-viral for treating COVID-19?
Open Orphan plc (ORPH) the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, is pleased to announce that its London-based subsidiary hVIVO has commenced the testing of an anti-viral for treating COVID-19 on behalf of its client Nearmedic International Ltd.
hVIVO has initiated work on this contract with Nearmedic International Ltd, a specialist pharmaceutical, biotechnological and medical business headquartered in Moscow, to test using hVIVO’s virology expertise and laboratory capability an anti-viral drug with potential utility for treating SARS-CoV2 (COVID-19) infections. This drug has both potential anti-viral and anti-inflammatory activity and as such could reduce both virus infectivity and disease severity respectively.
hVIVO will be testing its utility against a panel of viruses to include influenza virus, “normal”, circulating betacoronavirus and ultimately SARS-CoV2 (COVID-19).
Cathal Friel, Executive Chairman of Open Orphan, commented:
“We are very happy to be assisting in the battle against Covid-19 and are delighted to be working with Nearmedic International Ltd. hVIVO is a world leading provider of services to global vaccine and antiviral development companiesand our scientists have considerable knowledge from previous anti-viral trials which gives us confidence in our testing. We look forward to updating the market on a regular basis in the weeks and months ahead
Unfortunately, CF doesn't seem to be very communicative regards what's happening. No idea why???
But they also do test for private hospitals and doctors surgeries etc. Last time government took over private hospital s and their staff if you recall!
But Open orphan do have their own Covid 19 test! It's accurate so I've read! See opens Web site?
What's B2b???